Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors

Deborah T. Blumenthal*, Michal Yalon, Gilad W. Vainer, Alexander Lossos, Shlomit Yust, Lior Tzach, Emanuela Cagnano, Dror Limon, Felix Bokstein

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

77 Scopus citations

Fingerprint

Dive into the research topics of 'Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Neuroscience